Emcure Pharmaceuticals (NSE:EMCURE) FCF Margin %: 0.00% (As of Mar. 2026)


NSE:EMCURE Emcure Pharmaceuticals Ltd NSE:EMCURE
41 GF Score
Price ₹1,880.20
! 5 Warning Signs
View Full Analysis

What is Emcure Pharmaceuticals FCF Margin %?

Emcure Pharmaceuticals NSE:EMCURE +2.18% 41 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates NSE:EMCURE with a GF Score™ of 41/100. The stock has 5 warning signs investors should review. Among 955 Drug Manufacturers companies, Emcure Pharmaceuticals ranks better than 56.02% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Emcure Pharmaceuticals's Free Cash Flow for the three months ended in Mar. 2026 was ₹0 Mil. Emcure Pharmaceuticals's Revenue for the three months ended in Mar. 2026 was ₹24,697 Mil. Therefore, Emcure Pharmaceuticals's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Emcure Pharmaceuticals's current FCF Yield % is 1.11%.

The historical rank and industry rank for Emcure Pharmaceuticals's FCF Margin % or its related term are showing as below:

NSE:EMCURE' s FCF Margin % Range Over the Past 10 Years
Min: 4.3   Med: 6.12   Max: 12
Current: 4.3

During the past 6 years, the highest FCF Margin % of Emcure Pharmaceuticals was 12.00%. The lowest was 4.30%. And the median was 6.12%.

NSE:EMCURE's FCF Margin % is ranked better than
56.02% of 955 companies
in the Drug Manufacturers industry
Industry Median: 2.51 vs NSE:EMCURE: 4.30

Emcure Pharmaceuticals FCF Margin % Related Terms

Emcure Pharmaceuticals FCF Margin % Historical Data

* Premium members only.

The historical data trend for Emcure Pharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Emcure Pharmaceuticals FCF Margin % Chart

Emcure Pharmaceuticals Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
FCF Margin %
Get a 7-Day Free Trial 6.44 5.79 12.00 5.63 4.30

Emcure Pharmaceuticals Quarterly Data
Mar21 Mar22 Mar23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

NSE:EMCURE vs ZTS: FCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Emcure Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Emcure Pharmaceuticals FCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Emcure Pharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Emcure Pharmaceuticals's FCF Margin % falls into.


NSE:EMCURE
41GF Score
Emcure Pharmaceuticals Ltd NSE:EMCURE
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Emcure Pharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Emcure Pharmaceuticals's FCF Margin for the fiscal year that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (A: Mar. 2026 )/Revenue (A: Mar. 2026 )
=3958.58/92035.4
=4.30 %

Emcure Pharmaceuticals's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=0/24697.03
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Emcure Pharmaceuticals (NSE:EMCURE) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Emcure Pharmaceuticals and its competitors. Over the past decade, Emcure Pharmaceuticals' FCF Margin % has ranged from 4.30 to 12.00. According to the industry distribution chart, Emcure Pharmaceuticals ranks #420 out of 955 companies in the Drug Manufacturers industry, placing it in the top 44%.
Is Emcure Pharmaceuticals' FCF Margin % too high?
Emcure Pharmaceuticals' current FCF Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 4.30 to a high of 12.00. Based on the distribution chart, Emcure Pharmaceuticals ranks #420 out of 955 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Emcure Pharmaceuticals has a GF Score™ of 41/100, reflecting its overall financial health beyond just this single metric.
How does Emcure Pharmaceuticals' FCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Emcure Pharmaceuticals ranks #420 out of 955 companies for FCF Margin %. This puts Emcure Pharmaceuticals in the upper half of its industry. The industry median FCF Margin % is 2.51. Historically, Emcure Pharmaceuticals' own FCF Margin % has ranged from 4.30 to 12.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.51, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Emcure Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Emcure Pharmaceuticals's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Emcure Pharmaceuticals stock overvalued right now?
Emcure Pharmaceuticals (NSE:EMCURE) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Emcure Pharmaceuticals' overall GF Score™ is 41/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Emcure Pharmaceuticals (NSE:EMCURE), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Emcure Pharmaceuticals Business Description

Other Exchanges 544210:India
Address Plot No. P-1 and P-2, IT-BT Park, Phase II, M.I.D.C., Hinjawadi, Pune, MH, IND, 411 057
Emcure Pharmaceuticals Ltd an Indian pharmaceutical company engaged in developing, manufacturing and globally marketing a range of pharmaceutical products across several therapeutic areas. Its portfolio includes orals including solids, liquid orals and dry syrup/suspensions., injectables such as vials and pre-filled syringes, and forms such as lyophilized & liquid and biotherapeutics. The company operates in Derma, Women's Health, Cardiovascular, Neurology, Oncology, Vaccines, and Anti-infectives. Geographically, it operates in India, Europe, Canada, Vietnam, Dubai, and Other Countries.
41GF Score

Get the complete analysis for NSE:EMCURE

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,880.20
Price